Shreesh Ojha Selected Research

Shreesh Ojha Research Topics

Disease

33	Inflammation (Inflammations) 11/2022 - 12/2011
18	Neoplasms (Cancer) 11/2022 - 01/2016
18	Myocardial Infarction 06/2022 - 11/2010
17	Cardiotoxicity 07/2021 - 11/2010
13	Body Weight (Weight, Body) 04/2022 - 11/2014
9	Myocardial Ischemia (Ischemic Heart Diseases) 04/2021 - 11/2011
8	COVID-19 10/2021 - 01/2020
8	Reperfusion Injury 01/2020 - 01/2013
8	Ischemia 09/2018 - 09/2010
7	Parkinson Disease (Parkinson's Disease) 12/2022 - 01/2015
7	Neuroinflammatory Diseases 06/2022 - 01/2014
6	Hyperglycemia 04/2022 - 01/2014
6	Infections 07/2021 - 01/2017
5	Cardiovascular Diseases (Cardiovascular Disease) 04/2022 - 01/2017
5	Mitochondrial Diseases (Mitochondrial Disease) 11/2021 - 11/2018
3	Ulcer 04/2022 - 01/2018
3	Colitis 04/2022 - 01/2018
3	Hyperlipidemias (Hyperlipidemia) 02/2021 - 01/2016
3	Dyslipidemias (Dyslipidemia) 01/2021 - 01/2017
3	Alcoholism (Alcohol Abuse) 01/2020 - 09/2014
3	Neuralgia (Stump Neuralgia) 06/2019 - 01/2016
3	Necrosis 06/2019 - 11/2011
3	Poisoning 01/2015 - 03/2014
2	Neoplasm Metastasis (Metastasis) 06/2022 - 07/2021
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2022 - 07/2021
2	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2022 - 01/2020
2	Multiple Sclerosis 04/2022 - 07/2021
2	Type 2 Diabetes Mellitus (MODY) 10/2021 - 12/2011
2	Insulin Resistance 10/2021 - 12/2011
2	Fibrosis (Cirrhosis) 07/2021 - 01/2021
2	Pain (Aches) 01/2021 - 11/2018
2	Leukemia 01/2021 - 05/2019
2	Alcoholic Fatty Liver 12/2020 - 01/2017
2	Hypertension (High Blood Pressure) 12/2020 - 01/2016
2	Hypertrophy 07/2016 - 01/2014

Drug/Important Bio-Agent (IBA)

20	AntioxidantsIBA 04/2022 - 02/2011
17	Isoproterenol (Isoprenaline)FDA LinkGeneric 06/2022 - 11/2010
13	Pharmaceutical PreparationsIBA 05/2022 - 01/2015
10	CytokinesIBA 11/2022 - 01/2014
9	PhytochemicalsIBA 11/2022 - 01/2014
8	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2021 - 01/2016
6	EnzymesIBA 04/2022 - 11/2010
6	Biological ProductsIBA 01/2022 - 04/2016
6	Antiviral Agents (Antivirals)IBA 07/2021 - 01/2020
6	RotenoneIBA 10/2020 - 01/2015
5	Proteins (Proteins, Gene)FDA Link 06/2022 - 05/2017
5	LipidsIBA 04/2022 - 01/2020
5	SesquiterpenesIBA 09/2021 - 01/2016
5	CannabinoidsIBA 01/2021 - 05/2019
5	CB2 Cannabinoid ReceptorIBA 01/2021 - 09/2014
5	caryophylleneIBA 01/2021 - 07/2016
5	Neuroprotective AgentsIBA 10/2020 - 01/2016
4	Malondialdehyde (Propanedial)IBA 04/2022 - 01/2016
4	Glutathione (Reduced Glutathione)IBA 04/2022 - 01/2014
4	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 01/2017
4	nerolidolIBA 09/2021 - 01/2016
4	Streptozocin (Streptozotocin)FDA Link 02/2021 - 12/2011
4	bisabolol (levomenol)IBA 10/2020 - 10/2018
4	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 07/2020 - 01/2014
4	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 01/2016
4	Organophosphorus CompoundsIBA 01/2015 - 01/2014
3	Interleukin-6 (Interleukin 6)IBA 06/2022 - 01/2017
3	thymoquinoneIBA 06/2022 - 01/2015
3	Acetic Acid (Vinegar)FDA LinkGeneric 04/2022 - 01/2018
3	Peroxidase (Myeloperoxidase)IBA 04/2022 - 01/2018
3	FlavonoidsIBA 07/2021 - 01/2014
3	InflammasomesIBA 07/2021 - 01/2017
3	kaempferolIBA 01/2020 - 01/2016
3	Eplerenone (Inspra)FDA LinkGeneric 09/2018 - 01/2015
2	Superoxide DismutaseIBA 04/2022 - 01/2016
2	CatalaseIBA 04/2022 - 01/2016
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 04/2022 - 12/2020
2	LimoneneIBA 07/2021 - 01/2021
2	Monoterpenes (Monoterpenoids)IBA 07/2021 - 03/2019
2	Volatile Oils (Essential Oils)IBA 07/2021 - 01/2020
2	AnthracyclinesIBA 07/2021 - 01/2016
2	Free RadicalsIBA 07/2021 - 11/2020
2	VaccinesIBA 07/2021 - 01/2020
2	nootkatoneIBA 04/2021 - 11/2020
2	Cardiotonic Agents (Cardiac Stimulants)IBA 04/2021 - 01/2016
2	Blood Glucose (Blood Sugar)IBA 02/2021 - 01/2016
2	Therapeutic UsesIBA 02/2021 - 01/2020
2	Insulin (Novolin)FDA Link 12/2020 - 01/2017
2	Hypolipidemic Agents (Antihyperlipidemics)IBA 11/2020 - 01/2015
2	Apoptosis Regulatory ProteinsIBA 10/2020 - 01/2014
2	alloinIBA 01/2020 - 01/2020
2	Disulfiram (Antabuse)FDA Link 01/2020 - 10/2018
2	Omeprazole (Prilosec)FDA LinkGeneric 06/2019 - 01/2016
2	Mitogen-Activated Protein KinasesIBA 05/2017 - 04/2016
2	Receptor for Advanced Glycation End ProductsIBA 05/2017 - 01/2017
2	Advanced Glycation End ProductsIBA 05/2017 - 01/2017
2	mangiferinIBA 01/2017 - 04/2016
2	CholesterolIBA 01/2015 - 12/2011
2	naringinIBA 11/2014 - 12/2011

Therapy/Procedure

12	Therapeutics 11/2022 - 01/2016
6	Drug Therapy (Chemotherapy) 07/2021 - 01/2015
5	Subcutaneous Injections 04/2021 - 05/2012
4	Ligation 05/2017 - 01/2013
2	Precision Medicine 11/2021 - 11/2020
2	Intraperitoneal Injections 03/2019 - 01/2016